An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance
            (Q36597042)
        
    
                
                
scientific article published on 22 October 2012
            
    scientific article published on 22 October 2012
                    Language: